Apexigen apexigen.com


Public lists: Pharma Startups (4729)

Apexigen is a biopharmaceutical product development company advancing a pipeline of product candidates with the potential to address life-threatening and difficult to treat diseases. The company's technology platform enables the discovery and development of superior antibody product candidates that are able to impact previously inaccessible disease targets. Apexigen is actively developing products, either by itself or in collaboration with partners. The company's product portfolio includes human...Show all

Apexigen is a biopharmaceutical product development company advancing a pipeline of product candidates with the potential to address life-threatening and difficult to treat diseases. The company's technology platform enables the discovery and develop...Show all

Company (Alive / Active)

Phone: 650-931-6236

Fax:

863 Mitten Road
Suite 103
Burlingame, 94010
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Apexigen $20M Aug 7, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Apexigen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-cd40 antibodies and methods of use Oct 30, 2013 Jun 13, 2017 Patent
Anti-cd40 antibodies Jan 14, 2016 Jan 31, 2017 Patent
Anti-kdr antibodies and methods of use Nov 01, 2012 Sep 13, 2016 Patent
Methods of inhibiting proliferation of cd40-expressing cancer cells with anti-cd40 antibodies Feb 03, 2015 Feb 23, 2016 Patent
Anti-il-1β antibodies Sep 09, 2011 Jul 21, 2015 Patent
See all 12 patents